Literature DB >> 14256816

THE MECHANISM OF THE DEPRESSOR ACTION OF NORADRENALINE IN THE CAT.

S M KARIM.   

Abstract

In cats anaesthetized with pentobarbitone sodium or chloralose and injected with phenoxybenzamine or phentolamine, administration of (-)-noradrenaline (5 to 20 mug) produced a fall of blood pressure which resembled in onset and duration that produced by adrenaline under similar conditions. The depressor action of noradrenaline was due mainly to dilatation of the splanchnic blood vessels. This could be abolished by administration of pronethalol, a drug known to block sympathetic beta-receptors.

Entities:  

Keywords:  BLOOD PRESSURE; CATS; CHLORALOSE; EXPERIMENTAL LAB STUDY; NOREPINEPHRINE; PENTOBARBITAL; PHARMACOLOGY; PHENOXYBENZAMINE; PHENTOLAMINE; PRONETHALOL; SYMPATHOLYTICS

Mesh:

Substances:

Year:  1964        PMID: 14256816      PMCID: PMC1704007          DOI: 10.1111/j.1476-5381.1964.tb01612.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  10 in total

1.  EFFECT OF PRONETHALOL ON SOME INHIBITORY ACTIONS OF CATECHOLAMINES.

Authors:  S VANOV
Journal:  J Pharm Pharmacol       Date:  1963-11       Impact factor: 3.765

2.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).

Authors:  J W BLACK; J S STEPHENSON
Journal:  Lancet       Date:  1962-08-18       Impact factor: 79.321

3.  [Several adrenolytic drugs causing inversion of the hypertensive effects of adrenalin & noradrenalin in the rabbit].

Authors:  R HAZARD; J HAZARD; P MOUILLE
Journal:  Arch Int Pharmacodyn Ther       Date:  1957-12-01

4.  The nature of the reflex vasodilatation induced by epinephrine.

Authors:  C C GRUHZIT; W A FREYBURGER; G K MOE
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

5.  The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat.

Authors:  K H GINZEL; S R KOTTEGODA
Journal:  J Physiol       Date:  1954-02-26       Impact factor: 5.182

6.  Adrenergic inhibitory function in the rabbit; epinephrine reversal and isopropylnorepinephrine vasodepression.

Authors:  S C HARVEY; M NICKERSON
Journal:  J Pharmacol Exp Ther       Date:  1953-07       Impact factor: 4.030

7.  The presence of a sympathomimetic substance in extracts of mammalian heart.

Authors:  U S V Euler
Journal:  J Physiol       Date:  1946-07-15       Impact factor: 5.182

8.  Experiments on liver sympathin.

Authors:  J H Gaddum; L G Goodwin
Journal:  J Physiol       Date:  1947-01-15       Impact factor: 5.182

9.  Blood-pressure effects of noradrenaline and adrenaline with special reference to their antagonism by ergotoxine and other blocking agents.

Authors:  K I MELVILLE
Journal:  J Physiol       Date:  1951-04       Impact factor: 5.182

10.  The action of noradrenaline.

Authors:  J H BURN; D E HUTCHEON
Journal:  Br J Pharmacol Chemother       Date:  1949-12
  10 in total
  6 in total

1.  Proceedings: The mechanism of "adrenaline reversal" in the anaesthetized cat and rabbit.

Authors:  H C Grundy; H F Grundy
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Effects of pronethalol on the cardiovascular actions of catecholamines during blockade by phenoxybenzamine.

Authors:  J Garrett; A Malafaya-Baptista; W Osswald
Journal:  Br J Pharmacol Chemother       Date:  1966-09

3.  The mechanism of the pressor action of noradrenaline in pithed cats.

Authors:  S M Karim
Journal:  Br J Pharmacol Chemother       Date:  1966-05

4.  Further observations on the pressor action of propranolol.

Authors:  S O Kayaalp; R K Türker
Journal:  Br J Pharmacol Chemother       Date:  1967-08

5.  Effect of propranolol on alpha-adrenergic blockade in the dog and isolated rabbit aortic strip.

Authors:  G J Olivares; N T Smith; L Aronow
Journal:  Br J Pharmacol Chemother       Date:  1967-06

6.  Unexpected hypotension in catecholamine reversal: a case report.

Authors:  Yohei Okada; Wataru Ishi; Hiromichi Narumiya; Ryoji Liduka
Journal:  J Med Case Rep       Date:  2017-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.